Patent 9517202 was granted and assigned to Latitude Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.
The present invention is directed to phospholipid compositions and methods of preparation of phospholipid depots that are injectable through a fine needle. The phospholipid depots prepared by the methods described herein comprise nanometer-sized phospholipid particles and exhibit a higher degree of structural order compared to compositions prepared by other methods.